| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
3e-10 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |